The healthcare world is witnessing a significant shift in diabetes treatment with the introduction of GLP-1 patches. These systems offer a possibly more user-friendly alternative to subcutaneous administrations of GLP-1 receptor agonists, minimizing the need for daily needle pricks. The innovation administers the compound directly through the epide